• -
175 Results
Health insurance
HRMS Issue Brief #15: The Impact of the Affordable Care Act on Texas Workers
A larger percentage of Texas workers are getting health insurance through their employers now than before the implementation of the Affordable Care Act, according to a new report released by Rice University’s Baker Institute for Public Policy and the Episcopal Health Foundation.
Vivian Ho, Elena M. Marks, Philomene Balihe November 9, 2015
Patient and doctor
HRMS Issue Brief #14: Comparison of Affordability and Utilization of Health Care Services by Insured and Uninsured Adult Texans
Concerned about high medical bills, uninsured Texans are twice as likely as the insured to delay or forgo health care. That’s one of the findings of a new survey released today by Rice University’s Baker Institute for Public Policy and the Episcopal Health Foundation.
Vivian Ho, Elena M. Marks, Philomene Balihe August 31, 2015
Child staring out of a window
A Role for Policy: Asthma Interventions Require Supportive Policies for Long-term Impact
Asthma in children costs an estimated $27 billion annually for doctor visits, emergency department visits and hospitalizations. Not surprisingly, kids with asthma miss more days of school and do worse academically. The first step to the management and treatment of asthma is access to a primary care provider who can prescribe the necessary medications and develop an asthma action plan. However, if we want to have a significant impact on the negative consequences of this disease on our children, a multi-faceted approach that includes policy is an absolute must.
Quianta Moore July 9, 2015
Health insurance
HRMS Issue Brief #11: Effects of the Affordable Care Act on Health Insurance Coverage in Texas as of March 2015
The percentage of Texans without health insurance dropped 31 percent since enrollment began in the Affordable Care Act's (ACA) Health Insurance Marketplace, according to a new report released today by Rice University’s Baker Institute for Public Policy and the Episcopal Health Foundation.
Vivian Ho, Elena M. Marks April 30, 2015
Genome
Economic Perspective on Genomic Testing: Is It Worth the Cost?
Genomic testing is a rapidly growing field, especially in cancer medicine, where it can be used to match patients to the most effective targeted treatment. In the past decade, we have seen rapid growth in the number of new genomic tests that are available. However, genomic testing is usually very expensive, raising the question of whether the testing is worth the cost.
Chan Shen March 25, 2015